HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography

48 hours. The report includes both 3D images of the coronary anatomy and calculated functional information, including the estimated FFR values (known as FFR values). Clinicians can then CT use the report to help guide the management of suspected coronary artery disease. 2.3 HeartFlow FFR is intended for use in patients with stable, recent-onset chest CT pain and suspected angina. Because the safety and effectiveness of FFR CT analysis has not been evaluated in other patient subgroups, HeartFlow FFR is CT not recommended in patients who have an acute coronary syndrome or have had a coronary stent, coronary bypass surgery or myocardial infarction in the past month. 2.4 The company first received a CE mark in July 2011, covering all 1.X versions of the technology, including the current version, 1.7. 2.5 HeartFlow FFR costs £700 per test. A higher price of £888 is used in the CT company submission and assessment report. The cost was reduced in May 2015. 2.6 The claimed benefits of HeartFlow FFR in the case for adoption presented by CT the company were as follows: • Analysis is done using standard CCTA scans, without the need for additional imaging, radiation or medication. • It provides the
